Barry Berger Discusses Cologuard

BARRY BERGER, MD
Saturday, April 23, 2016
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.


Barry Berger, MD, Exact Sciences Corporation, discusses Cologuard, an at-home screening for colorectal cancer. 

Berger says the test is straightforward because it give a positive or negative answer, which is concluded by examining DNA and fecal hemoglobin in the sample that the patients provide. However, patients should know that Cologuard does not use inherited DNA for screening, but instead looks at changes in DNA that are a result of undergoing carcinogenisis. 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.